← FDA Drug Approvals (Drugs@FDA)

EZETIMIBE AND SIMVASTATIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL PHARMS CO · Approved 2017-11-21

Drug application

FDA Application #

ANDA208831

Application type

Abbreviated New Drug Application (Generic)

Brand name

EZETIMIBE AND SIMVASTATIN

Generic name

EZETIMIBE AND SIMVASTATIN

Active ingredients

EZETIMIBE; SIMVASTATIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

AMNEAL PHARMS CO

Manufacturer

Amneal Pharmaceuticals NY LLC

First approval

2017-11-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown